{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:18:26Z","timestamp":1792448306432,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jpsychires.2021.05.019","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:49:55Z","timestamp":1621298995000},"page":"71-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Registered clinical studies investigating psychedelic drugs for psychiatric disorders"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7223-7064","authenticated-orcid":false,"given":"Ashley N.","family":"Siegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-1785","authenticated-orcid":false,"given":"Shakila","family":"Meshkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Benitah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9110-7951","authenticated-orcid":false,"given":"Orly","family":"Lipsitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3568-8816","authenticated-orcid":false,"given":"Hartej","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanna M.W.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2021.05.019_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0099-9598(01)56005-8","article-title":"Chapter 1 ibogaine: a review","volume":"56","author":"Alper","year":"2001","journal-title":"Alkaloids - Chem. Biol."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00204-015-1513-x","article-title":"The hallucinogenic world of tryptamines: an updated review","volume":"89","author":"Araujo","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"19","key":"10.1016\/j.jpsychires.2021.05.019_bib4","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2217\/fon-2017-0722","article-title":"The next generation of therapy for multiple myeloma: a review of ongoing clinical trials utilizing ClinicalTrials.gov","volume":"14","author":"Barth","year":"2018","journal-title":"Future Oncol."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(88)90056-8","article-title":"Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites","volume":"149","author":"Battaglia","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-020-00748-y","article-title":"Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies","volume":"34","author":"Breeksema","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2021.05.019_bib7","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2021.05.019_bib8","series-title":"Four Terminally Ill Canadians Get Special Exemption to Use Psychedelic Therapy","author":"CTV News","year":"2020"},{"issue":"10","key":"10.1016\/j.jpsychires.2021.05.019_bib9","doi-asserted-by":"crossref","DOI":"10.2217\/imt-2018-0019","article-title":"Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy","volume":"10","author":"Cushman","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jpsychires.2021.05.019_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","article-title":"Ayahuasca: pharmacology, neuroscience and therapeutic potential","volume":"126","author":"Dom\u00ednguez-Clav\u00e9","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","article-title":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews","volume":"11","author":"dos Santos","year":"2018","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17470910802649470","article-title":"Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration","volume":"4","author":"Dumont","year":"2009","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/218296a0","article-title":"Personality structure as the main determinant of drug induced (Model) psychoses [35]","volume":"218","author":"Fischer","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2021.05.019_bib14","doi-asserted-by":"crossref","DOI":"10.1080\/14737175.2020.1826931","article-title":"The emerging role of psilocybin and MDMA in the treatment of mental illness","author":"Gill","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib15","doi-asserted-by":"crossref","first-page":"112749","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/02791072.1986.10472364","article-title":"Subjective reports of the effects of MDMA in a clinical setting","volume":"18","author":"Greer","year":"1986","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.jpsychires.2021.05.019_bib17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.tips.2017.08.003","article-title":"Psychedelic drugs in biomedicine","volume":"38","author":"Kyzar","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"Nichols","year":"2016","journal-title":"Psychedelics. Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2020.03.020","article-title":"Registered clinical trials investigating ketamine for psychiatric disorders","volume":"127","author":"Peyrovian","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib22","series-title":"Handbuch Psychoaktive Substanzen. Springer Reference Psychologie","article-title":"The history of psychedelics in medicine","author":"Sessa","year":"2016"},{"key":"10.1016\/j.jpsychires.2021.05.019_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2019.00138","article-title":"A review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy","volume":"10","author":"Sessa","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.05.019_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/02791072.2017.1320734","article-title":"Psilocybin-assisted therapy: a review of a novel treatment for psychiatric disorders","volume":"49","author":"Thomas","year":"2017","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.jpsychires.2021.05.019_bib25","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621002880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621002880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:19:53Z","timestamp":1758367193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395621002880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":23,"alternative-id":["S0022395621002880"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.05.019","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Registered clinical studies investigating psychedelic drugs for psychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}